UNSPSC 51453700: Anthelmintic thioxanthenes

Anthelmintic drugs made from compounds with three aromatic rings in linear arrangement with a sulfur in the center ring.

UNSPSC 51453700 Anthelmintic thioxanthenes, a Class code, shows minimal recent state and local procurement activity aligned with its nominal scope. The source records four recent opportunities tagged to this code, but only one—Seminole County, Florida's procurement for naloxone and drug deactivation systems—addresses health-related products remotely connected to pharmaceutical supplies. The other three opportunities involve generic multi-source pharmaceuticals and OTC products (Minnesota MMCAP cooperative purchasing and Texas HHS direct-to-manufacturer prescriptions RFI) and medical and first aid supplies for emergency response (City of Tampa Fire Department). None of these solicitations target anthelmintic thioxanthenes specifically, and the code appears to capture broad pharmaceutical and medical-supply procurement rather than the parasiticide class the code name suggests.

Activity spans multiple states and issuing bodies including state health agencies (Texas HHS, Minnesota Department of Administration), counties (Seminole County, Florida), cities (Tampa), and cooperative purchasing alliances (MMCAP serving Minnesota, Oregon, and other participants). Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a due date of July 26, 2023; the City of Tampa's IFB for medical and first aid supplies ($700,000 estimated contract value, designated as a sheltered market for certified small local business enterprises, due March 13, 2026); and Minnesota MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (proposals due March 26, 2026). The geographic spread reflects activity in Florida, Texas, Minnesota, and Oregon. The code exhibits misalignment between its classification name and actual procurement patterns, suggesting potential data-tagging issues or broad use as a default pharmaceutical-supply category across state and local systems.